ABSTRACT
Objective To determine the clinical relevance of brain temperature (TBr) variation in patients after traumatic brain injury (TBI).
Design Cohort study with prospective (healthy participant) and retrospective (TBI patient) arms.
Setting Single neuroimaging site in the UK (prospective arm); intensive care sites contributing to the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) High Resolution ICU (HR ICU) Sub-Study (retrospective arm).
Participants 40 healthy adults aged 20-40 years recruited for non-invasive brain thermometry and all patients up to May 2020 that had TBr measured directly and were not subjected to Targeted Temperature Management (TTM).
Main outcome measures A diurnal change in TBr (healthy participants); death in intensive care (patients).
Results In healthy participants, mean TBr (38.5 SD 0.4°C) was higher than oral temperature (36.0 SD 0.5°C), and 0.36°C higher in luteal females relative to follicular females and males (95% confidence interval 0.17 to 0.55, P=0.0006 and 0.23 to 0.49, P<0.0001, respectively). TBr increased with age, most notably in deep brain regions (0.6°C over 20 years; 0.11 to 1.07, P=0.0002). The mean maximal spatial TBr range was 2.41 (SD 0.46)°C, with highest temperatures in the thalamus. TBr varied significantly by time of day, especially in deep brain regions (0.86°C; 0.37 to 1.26, P=0.0001), and was lowest in the late evening. Diurnal TBr in cortical white matter across participants ranged from 37.0 to 40.3°C. In TBI patients (n=114), mean TBr (38.5 SD 0.8°C) was significantly higher than body temperature (TBo 37.5 SD 0.5°C; P<0.0001) and ranged from 32.6 to 42.3°C. Only 25/110 patients displayed a diurnal temperature rhythm; TBr amplitude was reduced in older patients (P=0.018), and 25/113 patients died in intensive care. Lack of a daily TBr rhythm, or an age increase of 10 years, increased the odds of death 12-fold and 11-fold, respectively (OR for death with rhythm 0.09; 0.01 to 0.84, P=0.035 and for death with ageing by 1 year 1.10; 1.05 to 1.16, P=0.0002). Mean TBr was positively associated with survival (OR for death 0.45 for 1°C increase; 0.21 to 0.96, P=0.040).
Conclusions Healthy TBr exceeds TBo and varies by sex, age, menstrual cycle, brain region, and time of day. Our 4-dimensional reference resource for healthy TBr can guide interpretation of TBr data in multiple clinical settings. Daily temperature variation is frequently disrupted or absent in TBI patients, in which TBr variation is of greater prognostic use than absolute TBr. Older TBI patients lacking a daily TBr rhythm are at greatest risk of death in intensive care. Appropriately controlled trials are needed to confirm the predictive power of TBr rhythmicity in relation to patient outcome, as well as the clinical utility of TTM protocols in brain-injured patients.
Registration UK CRN NIHR CPMS 42644; ClinicalTrials.gov number, NCT02210221.
What is already known on this topic
Brain temperature (TBr) can be measured directly in brain-injured patients via intracranial probe, but this method cannot be used in healthy individuals.
TBr can be measured non-invasively using magnetic resonance spectroscopy (MRS), but this method is not appropriate for most brain-injured patients.
Since physiological reference ranges for TBr in health have not been established, the clinical relevance of TBr variation in patients is unknown, and the use of TTM in neurocritical care remains controversial.
What this study adds
A reference map for healthy adult TBr at three clinically-relevant time points that can guide interpretation of TBr measured directly, or by MRS, in multiple clinical settings.
Our results suggest that loss of diurnal TBr rhythmicity after TBI increases the odds of intensive care death 12-fold; some TTM strategies may be clinically inappropriate.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
UK CRN NIHR CPMS 42644; ClinicalTrials.gov number, NCT02210221
Funding Statement
Funding: The prospective CiBraT Study was funded by a Medical Research Council Clinician Scientist Fellowship awarded to NMR (MR/S022023/1). JSON is supported by the Medical Research Council (MC_UP_1201/4). Some of the data contributing to the retrospective analysis were obtained in the context of CENTER-TBI, a large collaborative project (EC grant 602150) supported by the European Union's 7th Framework program (FP7/2007-2013). Additional funding for patient data collection was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). MJT acknowledges funding from the NHS Lothian Research and Development Office. This research was independent from funders. Funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval: The prospective study was co-sponsored by the University of Edinburgh and NHS Lothian (R&D Project Number 2019/0133). Ethics approval was obtained from the Academic and clinical office for research support (ACCORD) Medical Research Ethics Committee (AMREC; Study Number 18-HV-045). All participants provided written informed consent to participate. For TBI patient data analysis, approval was provided by NHS Scotland (14/SS/1086, R&D Department, University Hospitals Division NHS Lothian 2015/0171) for data collected at the Intensive Care Unit, Western General Hospital, Edinburgh, UK. For data extracted from other clinical sites via the CENTER-TBI database, the CENTER-TBI study was conducted in accordance with all relevant laws of the EU if directly applicable or of direct effect and all relevant laws of the country where the Recruiting sites were located, including but not limited to, the relevant privacy and data protection laws and regulations (the 'Privacy Law'), the relevant laws and regulations on the use of human materials, and all relevant guidance relating to clinical studies from time to time in force including, but not limited to, the ICH Harmonised Tripartite Guideline for Good Clinical Practice (CPMP/ICH/135/95) ('ICH GCP') and the World Medical Association Declaration of Helsinki entitled 'Ethical Principles for Medical Research Involving Human Subjects'. Informed Consent by the patients and/or the legal representative/next of kin was obtained, accordingly to the local legislations, for all patients recruited in the Core Dataset of CENTER-TBI and documented in the e-CRF. Ethical approval was obtained for each recruiting site. The list of sites, Ethical Committees, approval numbers and approval dates can be found on the website: https://www.center-tbi.eu/project/ethical-approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data sharing: Individual patient data contained within the CENTER-TBI database are not publicly available but permissions for access can be requested at https://www.center-tbi.eu/data. We are committed to sharing all other anonymised individual participant and patient data that would support the clinical community. All shareable items are available immediately upon publication and indefinitely, or ending 5 years following article publication, by reasonable request from the Lead Author at ninar@mrc-lmb.cam.ac.uk. Shareable items will be available to anyone who wishes to access them and for any purpose. Code for statistical modelling is provided in Supplementary Appendix 5.
